NewYork-Presbyterian offers advanced diagnosis and treatment of tumors of the adrenal, parathyroid, and thyroid glands, as well as endocrine tumors of the digestive tract such as carcinoid and pancreatic endocrine tumors. From minimally invasive surgery to advanced chemotherapy, immunotherapy, radiation therapy, and investigational anticancer approaches, we offer every kind of treatment for endocrine and neuroendocrine tumors.
World-Recognized Leaders in Cancer Care
U.S. News & World Report has named NewYork-Presbyterian a top-ranked hospital in the country for cancer treatment. We are home to two of the nation's leading cancer centers: the National Cancer Institute-designated Herbert Irving Comprehensive Cancer Center of New York-Presbyterian/Columbia University Irving Medical Center (one of only four comprehensive cancer centers in New York State) and the Weill Cornell Medicine Meyer Cancer Center in Partnership with NewYork-Presbyterian.
A Team of Endocrine Cancer Specialists
Our internationally recognized experts work together to provide seamless, coordinated care to our patients. A team of surgeons, endocrinologists, gastroenterologists, otolaryngologists, nuclear medicine physicians, pathologists, medical oncologists, and radiation oncologists regularly evaluates each patient’s case. A dedicated nurse navigator works closely with you, your families, and your primary care doctor to manage your care, schedule appointments, and answer questions.
Genetic Counseling and Testing
There are many genetic disorders involving endocrine and neuroendocrine glands. If you have a family history of multiple endocrine neoplasia types 1 (MEN1) and 2 (MEN2), you might benefit from meeting with a genetic counselor to discuss your risk of developing tumors in the adrenal, parathyroid, pituitary, pancreas and thyroid glands. If you choose to undergo genetic testing, our team of genetic counselors will explain your results, work with you to create a schedule for annual screenings as indicated and describe your treatment options.
Comprehensive Treatment Options
At NewYork-Presbyterian, we’re always looking towards the future of oncologic care. We offer innovative treatment options for endocrine tumors, including:
- Minimally invasive surgery. We use laparoscopic or robotic surgery to access abdominal endocrine tumors (adrenal and pancreas). Tumors are removed through less than two-centimeter incisions when possible. This allows for greater surgical precision and a more rapid recovery after surgery.
- Immunotherapy. Immunotherapies boost the power of the immune system to find and kill cancer cells. NewYork-Presbyterian has one of the strongest immunotherapy programs in the world, featuring pioneers in this field and clinical trials of novel immunotherapy approaches. Our oncology nurses oversee the administration of immunotherapies in our comfortable and modern infusion centers.
- Radiation therapy. We use radiation to treat adrenal gland tumors, thyroid cancer, and parathyroid cancer. We also use it after surgery in some people to kill any remaining cancer cells. NewYork-Presbyterian's radiation treatment centers are state-of-the-art facilities featuring the latest highly focused radiation technologies.
- Targeted therapies. We can target specific genes, proteins, or tissues in tumors that contribute to cancer growth. We routinely test tumors for a panel of mutations that then permit our physicians to precisely target the mutations that are driving the growth of the tumor.
- Chemotherapy. People with certain types of thyroid cancer may require chemotherapy to shrink tumors that have spread to other areas of the body.
- Hormone therapy. Hormone therapy is sometimes given to help stop tumors from growing. It is also given to patients with thyroid cancer if the thyroid gland was surgically removed.
Endocrine Cancer Research
NewYork-Presbyterian is committed to advancing our understanding of the cause of these cancers and the best treatment options. We have robust basic science research projects that aim to understand better the nature of thyroid, adrenal and gastrointestinal endocrine cancers and translational research protocols that aim to improve the treatment of the most advanced and aggressive endocrine cancers. We invest time and resources into clinical protocols to develop therapies that not only aim to increase the likelihood of cure in patients with endocrine cancers, but also improve their quality of life.